KUROSEAL Trademark

Trademark Overview


On Thursday, May 8, 2008, a trademark application was filed for KUROSEAL with the United States Patent and Trademark Office. The USPTO has given the KUROSEAL trademark a serial number of 79062216. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 8, 2018. This trademark is owned by Kuros Biosurgery AG. The KUROSEAL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical or medical formulations, namely, implants, coatings, surgical tissue sealants, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, surgical tissue sealants, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for...

Artificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts
kuroseal

General Information


Serial Number79062216
Word MarkKUROSEAL
Filing DateThursday, May 8, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, May 8, 2018
Registration Number4017687
Registration DateTuesday, August 30, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 30, 2010

Trademark Statements


Goods and ServicesPharmaceutical or medical formulations, namely, implants, coatings, surgical tissue sealants, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, surgical tissue sealants, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, surgical tissue sealants, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, surgical tissue sealants, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement"
Goods and ServicesArtificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts
Pseudo MarkKUROS SEAL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 6, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKuros Biosurgery AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameKuros Biosurgery AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameKuros Biosurgery AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, February 8, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 17, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, December 17, 2018INVALIDATION PROCESSED
Friday, December 7, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 7, 2018DEATH OF INTERNATIONAL REGISTRATION
Thursday, December 6, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 6, 2018CANCELLED SECTION 71
Thursday, January 25, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, May 18, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 9, 2012FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 9, 2012FINAL DISPOSITION PROCESSED
Wednesday, November 30, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 30, 2011REGISTERED-PRINCIPAL REGISTER
Monday, July 25, 2011TTAB RELEASE CASE TO TRADEMARKS
Monday, July 25, 2011OPPOSITION TERMINATED NO. 999999
Monday, July 25, 2011OPPOSITION DISMISSED NO. 999999
Friday, July 1, 2011PAPER RECEIVED
Tuesday, April 5, 2011PAPER RECEIVED
Saturday, October 23, 2010REFUSAL PROCESSED BY IB
Wednesday, September 29, 2010OPPOSITION INSTITUTED NO. 999999
Tuesday, September 28, 2010OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Tuesday, September 28, 2010OPPOSITION NOTICE (IB REFUSAL) CREATED
Friday, June 4, 2010NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 20, 2010NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, May 20, 2010NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, May 12, 2010EXPARTE APPEAL TERMINATED
Tuesday, May 11, 2010EXPARTE APPEAL TERMINATED
Tuesday, May 11, 2010EXPARTE APPEAL TERMINATED
Thursday, April 29, 2010EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 30, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2010PUBLISHED FOR OPPOSITION
Friday, February 19, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 19, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 18, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2010ASSIGNED TO LIE
Friday, February 12, 2010TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 12, 2010EX PARTE APPEAL-INSTITUTED
Friday, February 12, 2010JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, February 12, 2010EXPARTE APPEAL RECEIVED AT TTAB
Friday, November 27, 2009ASSIGNED TO EXAMINER
Tuesday, August 25, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 25, 2009FINAL REFUSAL E-MAILED
Tuesday, August 25, 2009FINAL REFUSAL WRITTEN
Monday, July 6, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 6, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 6, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 6, 2009REFUSAL PROCESSED BY IB
Tuesday, January 6, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 6, 2009REFUSAL PROCESSED BY MPU
Sunday, January 4, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, January 3, 2009NON-FINAL ACTION WRITTEN
Tuesday, December 23, 2008APPLICATION FILING RECEIPT MAILED
Friday, December 19, 2008ASSIGNED TO EXAMINER
Friday, December 19, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, December 18, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB